Navigation Links
Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
Date:10/12/2009

eolix is a leader in developing therapeutics that inhibit the cellular proteasome, a validated and well-characterized approach to treating certain hematologic cancers. Carfilzomib is the first in a new class of selective and irreversible proteasome inhibitors. To date, carfilzomib has demonstrated strong response rates in multiple studies and a potentially more tolerable safety profile than currently approved agents. An ongoing accelerated approval Phase 2b trial in patients with relapsed and refractory multiple myeloma is expected to complete enrollment in 2009 with data anticipated in the second half of 2010. Carfilzomib is also being evaluated in a companion Phase 2 trial in relapsed multiple myeloma. A Phase 3 trial evaluating carfilzomib in combination with lenalidomide and dexamethasone as a potential treatment option for patients with multiple myeloma is expected to begin in 2010. Carfilzomib is also being evaluated in a Phase 1b/2 study for solid tumor cancers. In addition, Proteolix has discovered additional next-generation proteasome inhibitors to which it holds worldwide development and commercialization rights, including an oral proteasome inhibitor and a selective immunoproteasome inhibitor.

"Treatment options in multiple myeloma have historically been limited, and there is a tremendous need to expand the treatment paradigm with agents offering an improved efficacy and safety profile," said Michael Kauffman, M.D., Ph.D., Chief Medical Officer at Proteolix. "Carfilzomib is in multiple ongoing clinical studies and has revealed clear single-agent activity in a heavily pre-treated multiple myeloma patient population, as well as being well tolerated alone, or in combination with Revlimid. Upcoming data for carfilzomib could support the potential near-term introduction of a novel therapy for this debilitating disease."

Cooley Godward Kronish LLP acted as legal advisor to Proteolix on this transaction.

About Multi
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Reportlinker Adds Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) Report
2. To: All Persons and Entities Who Purchased or Acquired Bristol-Myers Common Stock Between the Close of the Market on March 21, 2006, Through August 8, 2006, Inclusive
3. Avacor(R), Premier Provider of Hair Growth Solutions, Acquired By Investor Group.
4. Blue Cross Blue Shield of Michigan-owned DenteMax Acquired by Dental Network of America
5. Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization
6. Despite Generic Erosion of Key Brands, the Hospital-Acquired Gram Negative Infections Drug Market Will Increase by $1 Billion from 2008 to 2018
7. MedServe to be Acquired by Stericycle for $185 Million
8. Brockton Mayor, James E. Harrington Calls Press Conference to Unveil Newly Adopted Auto Emissions Technology Acquired With Federal Stimulus Money
9. Versailles Group Announces Accentus, Inc. Acquired by High Road Capital Partners
10. All Persons Who Purchased or Acquired the Common Stock of Sunrise Senior Living, Inc. (Sunrise) Between February 26, 2004 and July 28, 2006, Inclusive, and Were Damaged Thereby (The Class)
11. Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... July 14, 2014 MED-Ed Facilities is ... our next conference, April 7+8 in Boston at the ... at the recent event. Presentations by individuals or teams ... To review the types of sessions that were presented ... Submit your proposal today! , Conference Director, The ...
(Date:7/13/2014)... 2014 MillionaireCasket.com is a professional supplier of ... wood caskets are selling well in the global market. Recently, ... caskets and launched a special offer for all the ... all the company’s cherry caskets are made with superb materials. ... for people to show respect to the departed saint. MillionaireCasket.com ...
(Date:7/13/2014)... York (PRWEB) July 13, 2014 Intraocular ... Trends and Forecast 2013 - 2019 , Intraocular lens ... suffering from myopia or cataracts. The lenses are inserted ... the cataract surgery intraocular lens replaces the focusing power ... with original crystalline lens to deliver the light focusing ...
(Date:7/13/2014)... July 13, 2014 Victorian Hotel has ... promoting the rental of bikes for its "Cycle the ... Victorian Hotel to tour the area using a rental ... Bicycle enthusiasts love to call Vancouver home, as it ... cycle travel and picturesque journeys through the countryside. Vancouver ...
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
Breaking Medicine News(10 mins):Health News:MED-Ed Facilities Conference Call for Speakers Open 2Health News:Brand New Cherry Caskets Unveiled By China Casket Supplier MillionaireCasket.com 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4
... 18, 2011) Scientists at the Children,s Center for ... of Children,s Hospital Los Angeles today announced a breakthrough ... They have identified a protein called CD19-ligand (CD19-L) located ... facilitates the recognition and destruction of leukemia cells by ...
... 18 (HealthDay News) -- A disease the affects your legs ... About 9 million Americans over the age of 50 ... risk for heart attack, according to the Vascular Disease Foundation ... have the condition, the foundation says. PAD occurs when ...
... Center for World Health & Medicine at Saint Louis University ... forming a global research partnership that initially will focus on ... connected by a shared commitment to fight a devastating disease, ... scientists who formerly worked together in Chesterfield, Mo. GIBH ...
... Wittig, M.D., chief of the division of skin and ... Hackensack University Medical Center will present eleven different educational ... upcoming American Academy of Orthopaedic Surgeons Conference. Dr. Wittig ... practices in limb-sparing surgery. In 2009, he and his ...
... rich plasma (PRP) to promote healing in various surgeries, ... PRP did not improve healing after rotator cuff repair. ... investigators, will be presented at the upcoming American Orthopedic ... held Feb. 19 in San Diego, Calif., following the ...
... Parents and caregivers have traditionally relied on cribs, playpens ... The massive crib recalls followed by the announcement in ... Commission (CPSC) to ban drop-side cribs have caused many ... new study conducted by researchers at the Center for ...
Cached Medicine News:Health News:Scientists bioengineer a protein to fight leukemia 2Health News:Leg Discomfort Might Signal Heart Trouble 2Health News:Saint Louis U scientists partner on malaria research 2Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 2Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 3Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 4Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 5Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 6Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 7Health News:Study shows PRP, commonly used technique to improve healing, doesn't work in rotator cuff surgery 2Health News:Study shows PRP, commonly used technique to improve healing, doesn't work in rotator cuff surgery 3Health News:New study finds 9,500 ED visits related to cribs, playpens and bassinets each year in US 2Health News:New study finds 9,500 ED visits related to cribs, playpens and bassinets each year in US 3
(Date:7/13/2014)... 2014  Eli Lilly and Company (NYSE: ... non-clinical study in genetically engineered mice examining combination ... antibody N3pG and beta-secretase inhibitor BACE (LY2811376). Data ... in removing clumps of amyloid-beta protein in the ... lead to Alzheimer,s disease (AD) – than use ...
(Date:7/11/2014)... , July 11, 2014  Rock Creek Pharmaceuticals, ... company, today announced that the Food and Drug Administration ... provide comments on RCP,s Investigational New Drug ("IND") application ... trial in the US. Dr. Chris ... review and comments on our IND. When we receive ...
(Date:7/11/2014)... , July 11, 2014  Kindred Hospital ... to announce the opening of its new outpatient ... outpatient services to people with chronic, hard to ... which can lead to amputation, lower leg wounds ... have delayed closure, and traumatic injury wounds which ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2
... in Akron (ABIA) and the U.S. Food and Drug ... support and develop regulatory science for the safe and ... Effective today, the FDA and ABIA executed a Memorandum ... upon ABIA resources—including a library of test methods for ...
... Fero Industries, Inc. (OTCQB: FROI), announced today ... has completed the registration process to become a ... institutions within Mexico. This license, which is the ... Company to provide coverage to PEMEX (Petroleos Mexicanos), ...
Cached Medicine Technology:FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices 2FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices 3Fero Industries, Inc. Achieves First Certified Supplier Status to Distribute Sucanon® in Mexico 2Fero Industries, Inc. Achieves First Certified Supplier Status to Distribute Sucanon® in Mexico 3
For Detection of Bile Component in Reflux Disease...
... With the advance of digital imaging ... advancing towards digital formats, allowing for ... This advance in digital pathology imaging ... occurred in radiology, and which is ...
... Analyzer II is a ... to enumerate fluorescently labeled ... selected and aligned. The ... CellTracks® Analyzer II, a ...
These Iron Control Slides make an excellent addition to your laboratory. Packed ten (10) control slides per box. Use SDL's Snap n' Stain for Iron Staining Kit alongside to save time an money mixing r...
Medicine Products: